188 related articles for article (PubMed ID: 32842251)
21. Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens.
Tetikkurt S; Çelik E; Taş H; Cay T; Işik S; Usta AT
Mol Clin Oncol; 2018 Aug; 9(2):231-237. PubMed ID: 30101029
[TBL] [Abstract][Full Text] [Related]
22. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
23. [Expression and significance of bcl-2, bax and ER in foci of adenomyosis].
Li B; Wang L; Fan Y; Wang J; Guo D
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):923-7. PubMed ID: 23324193
[TBL] [Abstract][Full Text] [Related]
24. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
Park CK; Yoon G; Cho YA; Kim HS
Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
[TBL] [Abstract][Full Text] [Related]
26. Does the Increased Rate of Serous Component (≤25% vs. >25%) Increase Recurrence in Endometrial Cancer With Serous Plus Endometrioid Histology?
Kaban A; Topuz S; Sozen H; Salihoglu Y
J Obstet Gynaecol Can; 2019 Feb; 41(2):160-165. PubMed ID: 30316715
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological Characteristics of Ten Patients with Atypical Glandular Hyperplasia Transformation of Adenomyosis.
Zhu HL; Gao SY; Shen DH; Cui H
Chin Med J (Engl); 2016 Feb; 129(3):364-6. PubMed ID: 26831242
[No Abstract] [Full Text] [Related]
28. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
29. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
[TBL] [Abstract][Full Text] [Related]
30. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
[TBL] [Abstract][Full Text] [Related]
31. Coexistence of uterine adenomyosis is not associated with a better prognosis in endometrioid-type endometrial cancer.
Aslan K; Sarı ME; Yalçın HR; Yalçın İ; Cüylan ZF; Özdal B
Ir J Med Sci; 2020 Aug; 189(3):835-842. PubMed ID: 31970616
[TBL] [Abstract][Full Text] [Related]
32. P53 expression in adenomyosis in endometrial carcinoma patients.
Taskin M; Lallas TA; Shevchuk M; Barber HR
Gynecol Oncol; 1996 Aug; 62(2):241-6. PubMed ID: 8751556
[TBL] [Abstract][Full Text] [Related]
33. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
34. Malignant transformation of adenomyosis: literature review and meta-analysis.
Yuan H; Zhang S
Arch Gynecol Obstet; 2019 Jan; 299(1):47-53. PubMed ID: 30519753
[TBL] [Abstract][Full Text] [Related]
35. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
Quick CM; May T; Horowitz NS; Nucci MR
Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
[TBL] [Abstract][Full Text] [Related]
36. Atypical endometrial polyps and the incidence of endometrial cancer: a retrospective cohort study.
Jacobs I; Tibosch R; Geomini P; Coppus S; Bongers MY; van Hanegem N
BJOG; 2020 Jul; 127(8):994-999. PubMed ID: 32133762
[TBL] [Abstract][Full Text] [Related]
37. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
38. Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia.
Hahn HS; Chun YK; Kwon YI; Kim TJ; Lee KH; Shim JU; Mok JE; Lim KT
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):80-3. PubMed ID: 20185225
[TBL] [Abstract][Full Text] [Related]
39. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
40. Atypical mucinous glandular proliferations in endometrial samplings: follow-up and other clinicopathological findings in 41 cases.
Rawish KR; Desouki MM; Fadare O
Hum Pathol; 2017 May; 63():53-62. PubMed ID: 28232161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
